Cantarini Maria Chiara, Trevisani Franco, Morselli-Labate Antonio Maria, Rapaccini Gianludovico, Farinati Fabio, Del Poggio Paolo, Di Nolfo Maria Anna, Benvegnù Luisa, Zoli Marco, Borzio Franco, Bernardi Mauro
Dipartimento di Medicina Interna, Cardioangiologia, Epatologia, Alma Mater Studiorum-University of Bologna, Bologna, Italy.
Am J Gastroenterol. 2006 Jan;101(1):91-8. doi: 10.1111/j.1572-0241.2006.00364.x.
The aim of this study was to assess whether hepatocellular carcinoma occurring in the setting of hepatitis B or C virus infection has different prognosis.
We performed a multicentric case-control study comparing 102 pairs of patients affected by hepatitis B virus- or hepatitis C virus-related hepatocellular carcinoma. Patients were matched for sex (male/female: 84/18 pairs), age, center, and period of enrollment, underlying chronic liver disease (cirrhosis/chronic hepatitis: 97/5 pairs), Child-Pugh class (A/B/C: 70/25/7 pairs), hepatocellular carcinoma stage (nonadvanced/advanced: 50/52 pairs) and, when possible, modality of cancer diagnosis (75 pairs: 47 during and 28 outside surveillance).
In the whole population, patients with hepatitis B tended to have a poor prognosis than those with hepatitis C (p = 0.160), and this difference became statistically significant among the patients with an advanced hepatocellular carcinoma (p = 0.025). Etiology, Child-Pugh class, gross pathology, and alpha-fetoprotein were the significant independent prognostic factors in the whole population. The distribution of these prognostic factors did not differ between patients with hepatitis B or hepatitis C, both in the whole population and in the subgroup of advanced hepatocellular carcinomas.
Hepatitis B virus-related hepatocellular carcinomas have a greater aggressiveness than hepatitis C virus-related tumors, which becomes clinically manifest once they have reached an advanced stage.
本研究旨在评估在乙型或丙型肝炎病毒感染背景下发生的肝细胞癌是否具有不同的预后。
我们进行了一项多中心病例对照研究,比较了102对受乙型肝炎病毒或丙型肝炎病毒相关肝细胞癌影响的患者。患者按性别(男/女:84/18对)、年龄、中心、入组时期、潜在慢性肝病(肝硬化/慢性肝炎:97/5对)、Child-Pugh分级(A/B/C:70/25/7对)、肝细胞癌分期(非晚期/晚期:50/52对)进行匹配,并且在可能的情况下,按癌症诊断方式进行匹配(75对:47例在监测期间诊断,28例在监测外诊断)。
在整个人群中,乙型肝炎患者的预后往往比丙型肝炎患者差(p = 0.160),而在晚期肝细胞癌患者中,这种差异具有统计学意义(p = 0.025)。病因、Child-Pugh分级、大体病理和甲胎蛋白是整个人群中重要的独立预后因素。在整个人群和晚期肝细胞癌亚组中,乙型或丙型肝炎患者这些预后因素的分布没有差异。
乙型肝炎病毒相关的肝细胞癌比丙型肝炎病毒相关的肿瘤具有更大的侵袭性,一旦进入晚期,这种侵袭性就会在临床上显现出来。